Abstract
Performance anxiety consists of several symptoms experienced in the context of public performance and is classified in DSM-III-R under social phobia. Performance anxiety must be distinguished from panic disorder, generalized social phobia, and generalized anxiety disorder. Performance anxiety symptoms can be detrimental to both performer and performance. These symptoms can be controlled by the judicious use of beta-adrenergic blocking agents. The use of beta-adrenergic blocking agents should be considered as part of a psychiatric stress-management program for these patients.
Recommended Citation
Bourgeois, M.D., James A.
(1991)
"The Management of Performance Anxiety with Beta-Adrenergic Blocking Agents,"
Jefferson Journal of Psychiatry: Vol. 9:
Iss.
2, Article 5.
DOI: https://doi.org/10.29046/JJP.009.2.002
Available at:
https://jdc.jefferson.edu/jeffjpsychiatry/vol9/iss2/5